Kedrion has received orphan drug designation from the European Medicines [...]

Otsuka Pharmaceutical Europe has submitted a marketing authorisation application (MAA) [...]

AstraZeneca and Amgen’s Tezspire (tezepelumab) has received a positive opinion [...]

MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotech focused on microbiome-based [...]

Barcelona-based biotech advances Huntington’s programme as EMA backs orphan designation, [...]

Gilead Sciences has received a positive opinion from the Committee [...]

As global pharma grapples with shifting regulations, rising geopolitical tensions, [...]

MaaT Pharma has submitted a marketing authorisation application (MAA) to [...]

The integration of artificial intelligence into pharmacovigilance is prompting a [...]

Research from Bayes Business School and Merck KGaA identifies barriers [...]